USA Today (12/21, Garzella) reports, “Amid a nationwide ADHD drug shortage, patients are paying significantly more for medication to help them direct their focus at school, work and home.” This “shortage has placed financial pressure on families, forcing them to search for alternatives,” which are often “expensive brand-name drugs.”
This “upward trend can” also “be seen in the prices retail community pharmacies pay for several popular ADHD drugs, which a USA TODAY analysis found have outpaced inflation – and in some cases doubled or tripled in price – since Adderall fell into short supply starting in October 2022.”
Related Links:
— “ADHD drug prices rise as Adderall shortage leaves patients scrimping to fill prescriptions,” Cecila Garzella, USA Today, December 21, 2023